Miller, Michael B. http://orcid.org/0000-0002-6205-3314
Huang, August Yue http://orcid.org/0000-0002-0416-2854
Kim, Junho
Zhou, Zinan
Kirkham, Samantha L. http://orcid.org/0000-0002-5444-6636
Maury, Eduardo A. http://orcid.org/0000-0002-2211-8611
Ziegenfuss, Jennifer S. http://orcid.org/0000-0002-3828-0381
Reed, Hannah C.
Neil, Jennifer E.
Rento, Lariza http://orcid.org/0000-0002-9361-441X
Ryu, Steven C. http://orcid.org/0000-0003-0620-9609
Ma, Chanthia C.
Luquette, Lovelace J.
Ames, Heather M. http://orcid.org/0000-0002-5868-7672
Oakley, Derek H.
Frosch, Matthew P.
Hyman, Bradley T. http://orcid.org/0000-0002-7959-9401
Lodato, Michael A. http://orcid.org/0000-0003-4175-1073
Lee, Eunjung Alice
Walsh, Christopher A. http://orcid.org/0000-0002-0156-2238
Article History
Received: 12 June 2020
Accepted: 14 March 2022
First Online: 20 April 2022
Competing interests
: C.A.W. is a paid consultant (cash, no equity) to Third Rock Ventures and Flagship Pioneering (cash, no equity) and is on the Clinical Advisory Board (cash and equity) of Maze Therapeutics. No research support is received. These companies did not fund and had no role in the conception or performance of this research project. The remaining authors declare no competing interests.